Colorectal Cancer Screening
Colorectal Cancer Screening
复制标题
DOI：
10.1016/j.suc.2015.05.007
复制
发表时间：
2015-10-01
影响因子：
3.1
通讯作者：
Garborg, Kjetil
中科院分区：
文献类型：
--
作者：
Garborg, Kjetil
结直肠癌（CRC）是西方世界癌症发病率和死亡率的主要原因。手术和医疗管理的进步已经改善了结果;然而，当在症状阶段检测到CRC时，其预后往往很差。大多数结直肠癌病例是由可切除的明确的前驱病变发展而来的，无症状的，可治愈的疾病可以通过方便的非侵入性检测来检测。这些特征使CRC成为筛选的合适候选者，并且有几种选择可用。本文概述了证据确立CRC筛查试验随着沿着讨论新的测试和正在进行的研究。
Colorectal cancer (CRC) is a leading cause of cancer morbidity and mortality in the Western world. Advances in surgical and medical management have led to improved outcomes; however, the prognosis of CRC is often poor when detected at a symptomatic stage. Most cases of CRC develop over years from removable well-defined precursor lesions, and asymptomatic, curable disease may be detected by convenient noninvasive tests. These features make CRC a suitable candidate for screening, and several options are available. This article outlines the evidence for established CRC screening tests along with a discussion on newer tests and ongoing research.